JAZZ vs WRAP · P/E 1988, rev $4.07B vs rev $4.5M
Jazz Pharmaceuticals PLC (JAZZ) versus Wrap Technologies Inc (WRAP) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Wrap Technologies Inc (WRAP) is a scientific & technical instruments company listed on US.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported WRAP revenue for 2024-12-31 was $4.5M. Net income was -$5.9M. Revenue was down 26.5% from 2023-12-31 to 2024-12-31. WRAP currently screens at market cap $77.9M.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. WRAP currently screens at market cap $77.9M.
Not investment advice. Open the JAZZ and WRAP stock pages for the full models.
Not investment advice.